ClinicalTrials.Veeva

Menu

Compare the Healing Process of Idiopathic Macular Hole With Different Surgical Techniques

F

Federal University of São Paulo

Status

Unknown

Conditions

Macular Holes

Treatments

Procedure: Inverted ILM Peeling
Procedure: Conventional ILM Peeling

Study type

Interventional

Funder types

Other

Identifiers

NCT03888625
IMH2019

Details and patient eligibility

About

To compare anatomic and functional results, and to evaluate postoperatively the healing process in 2 different techniques for the closure of the macular holes (MH)

Full description

Patients with macular holes classified in stages 3 and 4 will be randomized into 2 groups. . In Group A, patients will undergo peeling with complete removal of the internal limiting membrane (ILM) and in the group B, the inverted ILM peeling technique will be performed. The 20% sulfur hexafluoride (SF6) gas will be used as a tamponade agent in all surgeries, and patients will be instructed to avoid the prone position for 5 days.

OCT images will be performed in the first 5 postoperative days and months 1, 3 and 6.

The primary outcome is anatomic closure of the MH closure in the month 6. The second outcomes are: mean best corrected visual acuity (BCVA) at month 6, mean change in the BCVA at month 6; integrity of the perifoveal external limiting membrane and ellipsoid zone on Optical Coherence Tomography (OCT); MH closure rate over time in days; functional improvement of microperimetry Statistical analysis will be performed with Student t-test and the p-value of ≤ 0.05 is considered significant.

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

> Stage 3 and 4 macular holes with visual acuity between 20/30 and 20/800 according to the ETDRS chart.

Exclusion criteria

  • Macular holes secondary to ocular trauma, myopia or retinal detachment
  • Any previous treatment for the macular hole
  • Evidence on examination of any diabetic retinopathy
  • History or presence of wet or dry age macular degeneration (AMD)
  • Presence of epiretinal membrane or prior uveitis
  • Any ocular surgery within 3 months before baseline
  • Intra or periocular infection

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Group A: Conventional ILM peeling
Active Comparator group
Description:
peeling with complete removal of the internal limiting membrane (ILM)
Treatment:
Procedure: Conventional ILM Peeling
GroupB: Inverted ILM Peeling
Active Comparator group
Description:
the inverted ILM peeling technique, in which the ILM is left in the edge of the macular hole and the free area is inverted over the macular hole before fluid-air exchange
Treatment:
Procedure: Inverted ILM Peeling

Trial contacts and locations

1

Loading...

Central trial contact

Luci p Silva, PhD, MBA; Mauricio Maia, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems